INSIDE

evismo receives the Innosuisse Certificate

February 2024, evismo receives Innosuisse certificate and thus confirms 'readiness' for sustainable growth.To the blog

evismo CardioFlex in the SRF health magazine Puls

January 2024, With CardioFlex, the heart rhythm and heart rate are measured when energy drinks are consumed and analysed by a specialist.  To the article

 Interview with Dr. med. Eva Schibli-Kaspar, DoktorHaus Fislisbach

November 2023, DoktorHaus Fislisbach has been using the Cardioflex long-term ECG service from evismo for around three years. Dr med. Eva. Schibli-Kaspar explains why in an interview. To the interview

Interview with the MPAs of GMPP

August 2023, We would like to use interviews to ensure an exchange of experiences among our customers. We are pleased to learn more about how GMPP's MPAs use CardioFlex.  To the interview

Interview with Bernd Eigenberger, MD, Deputy Head of Medical Center Medbase Kreuzlingen

April 2023, by conducting interviews with GPs, cardiologists and medical practice assistants, we want to ensure an exchange of experiences among our customers in order to jointly optimise the patient experience and increase the diagnostic yield. To the interview

Interview with Michel Wenger, Medical Director of Centramed

April 2023, by conducting interviews with GPs, cardiologists and medical practice assistants, we want to ensure an exchange of experiences among our customers in order to jointly optimise the patient experience and increase the diagnostic yield. To the interview

Podcast on Diagnostics-as-a-Service and vital signs monitoring

November 2022, Willemien van den Toorn, Co-Founder evismo, explains in the Health Terminal Podcast what Diagnostics-as-a-Service is and how they enable ambulatory vital signs monitoring with evismo. To the podcast

EHRA recommends AF screening

October 2022, the European Heart Rhythm Association (EHRA) recommends a broad approach to screening for atrial fibrillation for early detection of cardiac arrhythmias DE / FR / EN

evismo wins innovation prize

October 2022, evismo has participated in the public 'Call for Idea Funding' of the NTN Innovation Booster of Innosuisse. For the submitted project 'Smart Framework for Vital Sign Monitoring' evismo has won the innovation prize endowed with 20'000 Swiss Francs. The capital will be used to further optimize patient comfort and the quality of data transmission when wearing digital sensors. To the Innovation Booster

Three feature articles for the IFAS 

October 2022, For the IFAS-Expo 2022 we published three feature articles:

• Our long-term ECG service CardioFlex ( DE / FR /EN
• The widespread disease atrial fibrillation ( DE / FR / EN
• Our vision for Diagnostics-as-a-Service ( DE / FR / EN
  
  

Cost guarantees for long-term ECG obsolete

September 2022, The tariff commission of the Swiss Society of Cardiology has released new rate recommendations for long-term ECGs  DE / FR

New EHRA Guide

August 2022, the European Heart Rhythm Association (EHRA) recommends ECG-based devices as CardioFlex for early detection of cardiac arrhythmias DE / FR / EN

Innosuisse supports evismo

31. May, 2022, Innosuisse supports the development of algorithms for early detection and prediction of cardiac arrhythmias DE / FR / EN

Financing round of 1 million CHF

14. September, 2021,  evismo schliesst Finanzierungsrunde über 1 Million CHF für die Skalierung ab DE / FR / EN

Seed Financing Round

Zurich, Switzerland, July 12, 2018  - evismo AG is pleased to announce that its seed funding round with key supplier and development partner Bittium has closed.    To the announcement